Sal de cinc de rosuvastatina forma I cristalina
Sal de cinc de rosuvastatina (2:1) forma I cristalina de la fórmula I **Fórmula** que presenta un difractograma de polvo de rayos X que contiene los ángulos de difracción específicos de 6,621; 19,089; y 22,466 grados 2Θ medidos utilizando la radiación CuKα. The present invention relates to crystalli...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | IMRE, János RUZSICS, György CLEMENTIS, György BARTHA, Feren KAPUI, Imre KOVANYINE LAX, Györgyi MOROVJAN, György HOFFMANNE FEKETE, Valéria BARKOCZY, Jozsef SZENT-KIRALLYI , Zsuzsanna KRASZNAI, György SIMIG, Gyula SLEGEL, Péter NAGY, Kálmán VOLK, Balázs KESZTHELYI, Adrienn |
| description | Sal de cinc de rosuvastatina (2:1) forma I cristalina de la fórmula I **Fórmula** que presenta un difractograma de polvo de rayos X que contiene los ángulos de difracción específicos de 6,621; 19,089; y 22,466 grados 2Θ medidos utilizando la radiación CuKα.
The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2598162TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2598162TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2598162TT33</originalsourceid><addsrcrecordid>eNrjZNAPTsxRSElVSM7MSwbRRfnFpWWJxSWJJZl5iQpp-UW5iQqeCslFmUChHKAQDwNrWmJOcSovlOZmUHRzDXH20E0tyI9PLS5ITE7NSy2Jdw02MrW0MDQzCgkxNiZGDQD0Myrl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Sal de cinc de rosuvastatina forma I cristalina</title><source>esp@cenet</source><creator>IMRE, János ; RUZSICS, György ; CLEMENTIS, György ; BARTHA, Feren ; KAPUI, Imre ; KOVANYINE LAX, Györgyi ; MOROVJAN, György ; HOFFMANNE FEKETE, Valéria ; BARKOCZY, Jozsef ; SZENT-KIRALLYI , Zsuzsanna ; KRASZNAI, György ; SIMIG, Gyula ; SLEGEL, Péter ; NAGY, Kálmán ; VOLK, Balázs ; KESZTHELYI, Adrienn</creator><creatorcontrib>IMRE, János ; RUZSICS, György ; CLEMENTIS, György ; BARTHA, Feren ; KAPUI, Imre ; KOVANYINE LAX, Györgyi ; MOROVJAN, György ; HOFFMANNE FEKETE, Valéria ; BARKOCZY, Jozsef ; SZENT-KIRALLYI , Zsuzsanna ; KRASZNAI, György ; SIMIG, Gyula ; SLEGEL, Péter ; NAGY, Kálmán ; VOLK, Balázs ; KESZTHELYI, Adrienn</creatorcontrib><description>Sal de cinc de rosuvastatina (2:1) forma I cristalina de la fórmula I **Fórmula** que presenta un difractograma de polvo de rayos X que contiene los ángulos de difracción específicos de 6,621; 19,089; y 22,466 grados 2Θ medidos utilizando la radiación CuKα.
The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170125&DB=EPODOC&CC=ES&NR=2598162T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170125&DB=EPODOC&CC=ES&NR=2598162T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IMRE, János</creatorcontrib><creatorcontrib>RUZSICS, György</creatorcontrib><creatorcontrib>CLEMENTIS, György</creatorcontrib><creatorcontrib>BARTHA, Feren</creatorcontrib><creatorcontrib>KAPUI, Imre</creatorcontrib><creatorcontrib>KOVANYINE LAX, Györgyi</creatorcontrib><creatorcontrib>MOROVJAN, György</creatorcontrib><creatorcontrib>HOFFMANNE FEKETE, Valéria</creatorcontrib><creatorcontrib>BARKOCZY, Jozsef</creatorcontrib><creatorcontrib>SZENT-KIRALLYI , Zsuzsanna</creatorcontrib><creatorcontrib>KRASZNAI, György</creatorcontrib><creatorcontrib>SIMIG, Gyula</creatorcontrib><creatorcontrib>SLEGEL, Péter</creatorcontrib><creatorcontrib>NAGY, Kálmán</creatorcontrib><creatorcontrib>VOLK, Balázs</creatorcontrib><creatorcontrib>KESZTHELYI, Adrienn</creatorcontrib><title>Sal de cinc de rosuvastatina forma I cristalina</title><description>Sal de cinc de rosuvastatina (2:1) forma I cristalina de la fórmula I **Fórmula** que presenta un difractograma de polvo de rayos X que contiene los ángulos de difracción específicos de 6,621; 19,089; y 22,466 grados 2Θ medidos utilizando la radiación CuKα.
The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPTsxRSElVSM7MSwbRRfnFpWWJxSWJJZl5iQpp-UW5iQqeCslFmUChHKAQDwNrWmJOcSovlOZmUHRzDXH20E0tyI9PLS5ITE7NSy2Jdw02MrW0MDQzCgkxNiZGDQD0Myrl</recordid><startdate>20170125</startdate><enddate>20170125</enddate><creator>IMRE, János</creator><creator>RUZSICS, György</creator><creator>CLEMENTIS, György</creator><creator>BARTHA, Feren</creator><creator>KAPUI, Imre</creator><creator>KOVANYINE LAX, Györgyi</creator><creator>MOROVJAN, György</creator><creator>HOFFMANNE FEKETE, Valéria</creator><creator>BARKOCZY, Jozsef</creator><creator>SZENT-KIRALLYI , Zsuzsanna</creator><creator>KRASZNAI, György</creator><creator>SIMIG, Gyula</creator><creator>SLEGEL, Péter</creator><creator>NAGY, Kálmán</creator><creator>VOLK, Balázs</creator><creator>KESZTHELYI, Adrienn</creator><scope>EVB</scope></search><sort><creationdate>20170125</creationdate><title>Sal de cinc de rosuvastatina forma I cristalina</title><author>IMRE, János ; RUZSICS, György ; CLEMENTIS, György ; BARTHA, Feren ; KAPUI, Imre ; KOVANYINE LAX, Györgyi ; MOROVJAN, György ; HOFFMANNE FEKETE, Valéria ; BARKOCZY, Jozsef ; SZENT-KIRALLYI , Zsuzsanna ; KRASZNAI, György ; SIMIG, Gyula ; SLEGEL, Péter ; NAGY, Kálmán ; VOLK, Balázs ; KESZTHELYI, Adrienn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2598162TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IMRE, János</creatorcontrib><creatorcontrib>RUZSICS, György</creatorcontrib><creatorcontrib>CLEMENTIS, György</creatorcontrib><creatorcontrib>BARTHA, Feren</creatorcontrib><creatorcontrib>KAPUI, Imre</creatorcontrib><creatorcontrib>KOVANYINE LAX, Györgyi</creatorcontrib><creatorcontrib>MOROVJAN, György</creatorcontrib><creatorcontrib>HOFFMANNE FEKETE, Valéria</creatorcontrib><creatorcontrib>BARKOCZY, Jozsef</creatorcontrib><creatorcontrib>SZENT-KIRALLYI , Zsuzsanna</creatorcontrib><creatorcontrib>KRASZNAI, György</creatorcontrib><creatorcontrib>SIMIG, Gyula</creatorcontrib><creatorcontrib>SLEGEL, Péter</creatorcontrib><creatorcontrib>NAGY, Kálmán</creatorcontrib><creatorcontrib>VOLK, Balázs</creatorcontrib><creatorcontrib>KESZTHELYI, Adrienn</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IMRE, János</au><au>RUZSICS, György</au><au>CLEMENTIS, György</au><au>BARTHA, Feren</au><au>KAPUI, Imre</au><au>KOVANYINE LAX, Györgyi</au><au>MOROVJAN, György</au><au>HOFFMANNE FEKETE, Valéria</au><au>BARKOCZY, Jozsef</au><au>SZENT-KIRALLYI , Zsuzsanna</au><au>KRASZNAI, György</au><au>SIMIG, Gyula</au><au>SLEGEL, Péter</au><au>NAGY, Kálmán</au><au>VOLK, Balázs</au><au>KESZTHELYI, Adrienn</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Sal de cinc de rosuvastatina forma I cristalina</title><date>2017-01-25</date><risdate>2017</risdate><abstract>Sal de cinc de rosuvastatina (2:1) forma I cristalina de la fórmula I **Fórmula** que presenta un difractograma de polvo de rayos X que contiene los ángulos de difracción específicos de 6,621; 19,089; y 22,466 grados 2Θ medidos utilizando la radiación CuKα.
The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2598162TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Sal de cinc de rosuvastatina forma I cristalina |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A57%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IMRE,%20J%C3%A1nos&rft.date=2017-01-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2598162TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |